RxDoctor Payments Data

Emily Lutz, PA

Physician Assistant · Louisville, KYNPI 1902450117

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 93.3% of the total across 321 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 24 manufacturers reported payments, led by Novartis at 32.2% of the total. Among physician assistant clinicians in KY with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$8,782in general payments, 2019–2025

Across 321 payments — averaging $27.36 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novartis$3K
  • Johnson & Johnson$2K
  • AbbVie$1K
  • E.r. Squibb & Sons, L.L.C.$750
  • Galderma Laboratories, L.p.$342
  • Regeneron Healthcare Solutions, Inc.$334
  • plus $2K from 18 others

What the payments were for

  • Food & beverage$8,19493%
  • Education$5887%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$8,782 in reported general payments places this provider in the 95th percentile of 1,448 physician assistant providers in Kentucky.

See all physician assistant providers in Kentucky

Medicare billing

Part B allowed, 2024
$124,042
Medicare patients
626
Services billed
2,743

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Skyrizi PenRisankizumab-Rzaa13$264,697
Clobetasol Propionate103$3,740
Fluorouracil34$2,590
Triamcinolone Acetonide217$2,443
Tacrolimus14$1,528
Ketoconazole102$1,520
Clindamycin Phosphate41$1,479
Doxycycline Monohydrate39$1,131
Betamethasone Dipropionate12$867
Metronidazole14$641
Imiquimod11$394
Hydrocortisone44$164
Mupirocin30$123
Doxycycline Hyclate17$95

Paid to pharmacies, not to this prescriber.

Other physician assistant in Louisville

See the full list for Kentucky

Where these figures come from

Is this you, or does something look wrong? →